Soiken Holdings: change report
Soiken Holdings: Confirmation
Soiken Holdings: Half Year Report - Term 31 (2024/07/01 - 2025/06/30)
Soiken Holdings: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/6 [Japanese GAAP] (consolidated)
Soiken Holdings: (Correction) Partial correction to the timely disclosure document “Notice Concerning Patent Acquisition of Our Subsidiary “NRL Pharma Co., Ltd.”
Soiken Holdings: Notice regarding the patent acquisition of our subsidiary “NRL Pharma Co., Ltd.”
Soiken Holdings: Notice regarding a business partnership with Medifellow Co., Ltd. ~Relieving health anxiety through remote health consultations with specialists ~
Soiken Holdings: Summary of financial results for the 1st quarter of the fiscal year ending 2025/6 [Japanese GAAP] (consolidated)
Soiken Holdings: Extraordinary Report
Soiken Holdings: Corporate Governance Report 2024/09/27
Soiken Holdings: Internal Control Report - 30th Period (2023/07/01 - 2024/06/30)
Soiken Holdings: Confirmation letter
Soiken Holdings: Financial Report - 30th Term (2023/07/01 - 2024/06/30)
Soiken Holdings: Explanatory materials on business plans and growth potential
Soiken Holdings: 2024 Annual General Meeting of Shareholders Convocation Notice
Soiken Holdings: Financial results report (consolidated) for June 2024 based on Japanese standards.
Soiken Holdings: Announcements of individual stocks regarding revisions to financial estimates and dividend estimates (no dividends), reduction of director's compensation, as well as the forecast of consolidated results and dividend estimates for the fiscal year ending June 2025.
Soiken Holdings: Announcement of Changes in Representative Directors and Board Members
Soiken Holdings: Confirmation letter
Soiken Holdings: Quarterly Report - 30th Quarter 3rd Quarter (2024/01/01 to 2024/03/31)